Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: Alternatives to direct ophthalmic artery catheterization

American Journal of Neuroradiology

Volumn 33, Issue 8, 2012, Pages 1608-1614

  Klufas, M A ^a,b   Gobin, Y P ^a   Marr, B ^b   Brodie, S E ^c   Dunkel, I J ^b   Abramson, David H ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN HYDROGEN TARTRATE; CARBOPLATIN; MELPHALAN; TOPOTECAN;

ARTERY CATHETERIZATION; ARTICLE; BALLOON OCCLUSION; BLOOD TRANSFUSION; BRONCHOSPASM; CANCER CONTROL; ELECTRORETINOGRAM; EYELID EDEMA; FEBRILE NEUTROPENIA; FOLLOW UP; HAIR LOSS; HUMAN; HYPEREMIA; INTRAOCULAR TUMOR; MAJOR CLINICAL STUDY; NASAL HAIR LOSS; NEUTROPENIA; OPHTHALMIC ARTERY; PINEAL BODY TUMOR; RETINOBLASTOMA; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAROTID ARTERY, INTERNAL; CATHETERIZATION; ELECTRORETINOGRAPHY; HUMANS; INFUSIONS, INTRA-ARTERIAL; MENINGEAL ARTERIES; OPHTHALMIC ARTERY; RADIOGRAPHY, INTERVENTIONAL; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 84866343611     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3019     Document Type: Article

References (27)

1. Abramson DH, Dunkel IJ, Brodie SE, et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 2008;115:1398-404, 1404.e1. Epub 2008 Mar 14.
2. Abramson DH, Dunkel IJ, Brodie SE, et al. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy. Arch Ophthalmol 2010;128:370-72
3. Abramson DH, Dunkel IJ, Brodie SE, et al. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 2010;117:1623-29. Epub 2010 Apr 9
4. Abramson DH. Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'chemosurgery' the first Stallard lecture. Br J Ophthalmol 2010;94:396-99
5. Gobin YP, Dunkel IJ, Marr BP, et al. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol 2011;129:732-37
6. Reese AB, Hyman GA, Merriam GR Jr, et al. Treatment of retinoblastoma by radiation and triethylenemelamine. AMA Arch Ophthalmol 1954;53:505-13
7. Hyman GA, Reese AB. Combination therapy of retinoblastoma with triethylene melamine and radiotherapy. J Am Med Assoc 1956;162:1368-73
8. Hayreh SS. Orbital vascular anatomy. Eye (Lond) 2006;20:1130-44 (Pubitemid 44515574)
9. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol 2004;9:69-73 (Pubitemid 38619319)
10. Gobin YP, Cloughesy TF, Chow KL, et al. Intra-arterial chemotherapy for brain tumors by using a spatial dose fractionation algorithm and pulsatile delivery. Radiology 2001;218:724-32 (Pubitemid 32172554)
11. Brodie SE, Gobin YP, Dunkel IJ, et al. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol 2009;119:13-22
12. Marr B, Gobin PY, Dunkel IJ, et al. Spontaneously resolving periocular erythema and ciliary madarosis following intra-arterial chemotherapy for retinoblastoma. Middle East Afr J Ophthalmol 2010;17:207-09
13. Vajzovic LM, Murray TG, Aziz-Sultan MA, et al. Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma. Clin Ophthalmol 2011;5:171-76. Epub 2011 Feb 10
14. Cooke D, Farid H, Kim W, et al. Zygomatico-orbital intra-arterial melphalan infusion for intraocular retinoblastoma. J Neurointerv Surg 2012;4:e16
15. Pham CT, Blanc R, Rouic LL, et al. Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma. Neuroradiology 2011 Nov 18. [Epub ahead of print]
16. Kiribuchi M, Hasegawa H. Retrograde infusion of anti-cancer drugs to the ophthalmic artery for intra ocular malignant tumors [in Japanese]. Iryo 1968;22:772-76
17. Hayreh SS, Dass R. The ophthalmic artery. I. Origin and intra-cranial and intra-canalicular course. Br J Ophthalmol 1962;46:65-98
18. Benz MS, Scott IU, Murray TG, et al. Complications of systemic chemotherapy as treatment of retinoblastoma. Arch Ophthalmol 2000;118:577-78 (Pubitemid 30203155)
19. Abramson DH, Beaverson KL, Chang ST, et al. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma. Arch Ophthalmol 2004;122:1316-23 (Pubitemid 39180851)
20. Abramson DH, Melson MR, Dunkel IJ, et al. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology 2001;108:1868-76 (Pubitemid 32905948)
21. Wong FL, Boice JD Jr, Abramson DH, et al. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA 1997;278:1262-67 (Pubitemid 27435614)
22. Murphree AL, Villablanca JG, Deegan WF 3rd, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 1996;114:1348-56 (Pubitemid 26398720)
23. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000;18:12-17 (Pubitemid 30036331)
24. Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002;133:657-64 (Pubitemid 34462014)
25. Rizzuti AE, Dunkel IJ, Abramson DH. The adverse events of chemotherapy for retinoblastoma: what are they? Do we know? Arch Ophthalmol 2008;126:862-65 (Pubitemid 351831340)
26. Jehanne M, Lumbroso-Le Rouic L, Savignoni A, et al. Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma. Pediatr Blood Cancer 2009;52:637-43
27. Gombos DS, Hungerford J, Abramson DH, et al. Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor? Ophthalmology 2007;114:1378-83 (Pubitemid 47008929)